Blumberg L, Enria D, Bausch DG. Viral haemorrhagic fevers. In: Farrar J, Hotez P, Junghanss T, Kang G, Lalloo D, White N, editors. Manson's tropical infectious diseases. New York: Elsevier; 2014. p. 171-94.
Romanowski V, Pidre M, Ferrelli ML, Bender C, Gomez R. Argentine hemorrhagic fever. In: Singh SK, Ruzek D, editors. Viral hemorrhagic fevers. Boca Raton (FL): CRC Press; 2013. p. 317-38.
SAVE. Argentine Society of Virology and Argentine Association of Microbiology. Argentine Hemorrhagic Fever. Position paper, 2019 [in Spanish] [cited 2020 Jan 25]. https://save.org.ar/noticias-de-interes/posicion-sobre-fha.
Vieth S, Drosten C, Charrel R, Feldmann H, Günther S. Establishment of conventional and fluorescence resonance energy transfer-based real-time PCR assays for detection of pathogenic New World arenaviruses. J Clin Virol. 2005;32:229-35. https://doi.org/10.1016/j.jcv.2004.07.011.
Gowen BB, Juelich TL, Sefing EJ, Brasel T, Smith JK, Zhang L, et al. Favipiravir (T-705) inhibits Junín virus infection and reduces mortality in a guinea pig model of Argentine hemorrhagic fever. PLoS Negl Trop Dis. 2013;7:e2614. https://doi.org/10.1371/journal.pntd.0002614.
Westover JB, Sefing EJ, Bailey KW, Van Wettere AJ, Jung K-H, Dagley A, et al. Low-dose ribavirin potentiates the antiviral activity of favipiravir against hemorrhagic fever viruses. Antiviral Res. 2016;126:62-8. https://doi.org/10.1016/j.antiviral.2015.12.006.
Raabe VN, Kann G, Ribner BS, Morales A, Varkey JB, Mehta AK, et al.; Emory Serious Communicable Diseases Unit. Favipiravir and ribavirin treatment of epidemiologically linked cases of Lassa fever. Clin Infect Dis. 2017;65:855-9. https://doi.org/10.1093/cid/cix406.
Enria DA, Briggiler AM, Sánchez Z. Treatment of Argentine hemorrhagic fever. Antiviral Res. 2008;78:132-9. https://doi.org/10.1016/j.antiviral.2007.10.010.
Peters CJ, Kuehne RW, Mercado RR, Le Bow RH, Spertzel RO, Webb PA. Hemorrhagic fever in Cochabamba, Bolivia, 1971. Am J Epidemiol. 1974;99:425-33. https://doi.org/10.1093/oxfordjournals.aje.a121631.